ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,394.59
      0.09%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. ETFs
      4. UK
      5. LSE
      6. Ls 2x Salesforc (CRME)

      7. Ls 2x Salesforc (CRME) News

      CRME

      Ls 2x Salesforc (CRME)

      Ls 2x Salesforc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:CRME
      DateTimeSourceHeadlineSymbolCompany
      04/24/202310:47AMUK RegulatoryLeverage Shares PLC Issuer Call Redemption ConfirmationLSE:CRMELs 2x Salesforc
      12/21/20095:05PMPR Newswire (US)Cardiome Pharma Corp. Permitting Automatic Securities Disposition and Purchase PlansLSE:CRME
      12/17/20096:00PMPR Newswire (US)Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator StudyLSE:CRME
      11/09/20098:40AMPR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
      11/06/20096:00PMPR Newswire (US)Cardiome to Release Third Quarter ResultsLSE:CRME
      11/02/20092:35PMPR Newswire (US)Cardiome To Present At Oppenheimer Healthcare ConferenceLSE:CRME
      10/28/20094:58PMPR Newswire (US)Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 TrialLSE:CRME
      10/16/20098:54PMPR Newswire (US)Cardiome Pharma Corp. Announces Final Results of Tender OfferLSE:CRME
      10/14/20096:00AMPR Newswire (US)Cardiome Pharma Corp. Announces Preliminary Results of Tender OfferLSE:CRME
      09/01/20092:57PMPR Newswire (US)Cardiome Pharma Corp. Announces Commencement of US$27.5 Million Tender OfferLSE:CRME
      08/28/20091:30PMPR Newswire (US)Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of LSE:CRME
      08/25/20095:11PMPR Newswire (US)Cardiome Pharma Corp. Announces Tender Offer To Purchase Up To US$27.5 Million Of Its Common SharesLSE:CRME
      08/11/20097:45AMPR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
      08/10/20097:45PMPR Newswire (US)Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol AgreementLSE:CRME
      08/10/20094:35PMPR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
      08/03/20095:16PMPR Newswire (US)Cardiome Announces Management TransitionLSE:CRME
      07/28/200911:45AMPR Newswire (US)Cardiome Achieves Milestone From Collaboration With Merck Co., Inc.LSE:CRME
      05/19/20098:30AMPR Newswire (US)Cardiome Announces That Collaboration and License Agreement with Merck & Co., Inc. Now EffectiveLSE:CRME
      05/15/20094:05PMPR Newswire (US)Cardiome Reports First Quarter ResultsLSE:CRME
      04/08/20096:13PMPR Newswire (US)Cardiome to Hold Conference CallLSE:CRME
      11/28/20085:31PMPR Newswire (US)Cardiome Discloses Chairman And CEO's Involuntary Share SaleLSE:CRME
      11/14/20086:40PMPR Newswire (US)Cardiome Reports Third Quarter ResultsLSE:CRME
      10/23/200810:40PMPR Newswire (US)Cardiome Announces Filing Of Shelf Registration StatementLSE:CRME
      10/09/200812:20PMPR Newswire (US)Cardiome Provides Regulatory UpdateLSE:CRME
      08/12/20084:05PMPR Newswire (US)Cardiome Reports Second Quarter ResultsLSE:CRME
      08/11/20084:30PMPR Newswire (US)Cardiome to Release Second Quarter Results and Hold Conference CallLSE:CRME
      08/11/20089:18AMPR Newswire (US)Cardiome And Astellas Announce Receipt Of FDA Approvable Letter For KYNAPID(TM)LSE:CRME
      07/23/20082:10PMPR Newswire (US)Cardiome Announces Preferred Share FinancingLSE:CRME
      07/14/20088:25AMPR Newswire (US)Cardiome Announces Positive Phase 2b Results For Oral VernakalantLSE:CRME
      07/13/200812:00PMPR Newswire (US)Cardiome To Hold Conference CallLSE:CRME
       Showing the most relevant articles for your search:LSE:CRME